Biotech and pharmaceutical Postgraduate study

Biotech and pharmaceutical Postgraduate study

Dr. Solà-Morales has been selected to become one of the professors that will teach in this postgraduate study provided by the IQS (Instituto Químico de Sarrià). The Biotech and pharmaceutical Postgraduate study combines the acquisition of essential knowledge (lectures, mentoring, round-tables discussions…) with the development of negotiation and problem solving capabilities ( case studies, workshops, group works…). The program has been designed to students that are willing to develop their professional potential in companies of the biotech or pharma sectors, according to the demand of such companies for high skilled workers. The objectives of this postgraduate are: The Biotech and pharmaceutical Postgraduate study prepare the students to face successfully an international, professional and competitive environment and to be able to adapt to a changing environment. More specifically: Acquire business vision Add real value to the companies based on the knowledge acquire during the training Analytical capability Learn how to work in multicultural environments where English is the principal communication...
ISPOR 20th annual European congress

ISPOR 20th annual European congress

From 4th to 8th November 2017 it will be held in Glasgow, Scotland, the ISPOR 20th annual European congress. ISPOR is recognized globally as the leading scientific and educational organization for HEOR (health economics and outcomes research) and its use in health care decisions. ISPOR Glasgow provides a forum for discussion and dissemination of HEOR information. The congress is a great opportunity collaborate and network with colleagues in the field, and hear about innovative research methods and new health policy developments. Reflecting on revolutionary transformations affecting today’s health care, ISPOR Glasgow will address medical technology development, health technology assessment, and policy and clinical decision making while exploring the theme, The Evolution of Value in Health Care. Dr. Sola Morales will discuss about the topic that in 1999, the EU enacted legislation to foster the introduction of new Orphan Medicinal Products (OMP) into the market. To date only partial evaluations of the success of this legislation have been made, so this analysis investigates the outcomes of the OMP legislation from a broader perspective. It is possible to find the program in this...

Inscripciones abiertas al 1er Máster de Contratación Pública Sanitaria y Compliance

El pasado viernes día 27 se celebró en el Salón de Actos del Hospital Universitario Clínico de San Carlos de Madrid el acto de inauguración del 1er Máster de Contratación Pública Sanitaria y Compliance. Este nuevo máster, que se inicia en enero 2016 y está coordinado por la consultora especialista en contratación pública sanitaria Tesera de Hospitalidad y la Sociedad Española de Directivos de la Salud (SEDISA), aporta un valor diferencial a los profesionales que centran su actividad profesional en este campo y necesitan una puesta al día con una visión de 360° eminentemente práctica. Ya están abiertas las inscripciones, hasta el 11 de enero de 2016, y HITT va a participar como ponente del máster, en una sesión que se celebrará en el mes de mayo y en la que se explicaran ejemplos y limitaciones de los Acuerdos de Riesgo Compartido. On Friday the 27th November, at the Salón de Actos of the Hospital Clínico Universitario San Carlos in Madrid, the opening ceremony of the 1st Master of Public Health Contracting and Compliance engaged several hospital purchasing leaders. This Master is coordinated by the consulting company Tesera de Hospitalidad and the spanish association of health directors – SEDISA, and HITT participates as an invited speaker to explain the limitations and examples of Risk Sharing Schemes. Descargar díptico informativo en .pdf / Download brochure...